Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus

Clinical Microbiology and Infection

Volumn 17, Issue 5, 2011, Pages 732-737

  Lemaitre, M ^a,b   Leruez Ville, M ^c   De Lamballerie, X N ^d   Salez, N ^d   Garrone, P ^e   Fluckiger, A C ^e   Klatzmann, D ^f   Carrat, F ^a,b,g  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d Aix Marseille University IRD 190 Inserm 1207   (France)

^e UNIVERSITÉ DE LYON   (France)

^f CNRS   (France)

^g HÔPITAL SAINT ANTOINE   (France)

Author keywords

Antibodies; Cross reactions; H1N1 subtype immunology; Human immunology; Influenza; Influenza A virus; Pandemic; Seasonal

Indexed keywords

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CROSS REACTION; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; PANDEMIC INFLUENZA; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS STRAIN;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 79955384698     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03352.x     Document Type: Article

References (22)

1. Smith GJD, Vijaykrishna D, Bahl J et al. Origins and evolutionary genomics of the 2009 swine-origin h1n1 influenza a epidemic. Nature 2009; 459: 1122-1125.
2. Chowell G, Bertozzi SM, Colchero MA et al. Severe respiratory disease concurrent with the circulation of h1n1 influenza. N Engl J Med 2009; 361: 674-679.
3. Monto AS, Ohmit SE, Margulies JR, Talsma A. Medical practice-based influenza surveillance: viral prevalence and assessment of morbidity. Am J Epidemiol 1995; 141: 502-506.
4. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza a h1n1 infection in england: a cross-sectional serological study. Lancet 2010; 375: 1100-1108.
5. Hancock K, Veguilla V, Lu X et al. Cross-reactive antibody responses to the 2009 pandemic h1n1 influenza virus. N Engl J Med 2009; 361: 1945-1952.
6. Katz J, Hancock K, Veguilla V et al Serum cross-reactive antibody response to a novel influenza a (h1n1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009; 58: 521-524.
7. Ikonen N, Strengell M, Kinnunen L et al. High frequency of cross-reacting antibodies against 2009 pandemic influenza a(h1n1) virus among the elderly in finland. Euro Surveill 2009; 15: pii: 19478.
8. Greenbaum JA, Kotturi MF, Kim Y et al. Pre-existing immunity against swine-origin h1n1 influenza viruses in the general human population. Proc Natl Acad Sci U S A 2009; 106: 20365-20370.
9. Vaux S, Valette M, Enouf V et al. Surveillance épidémiologique et virologique de la grippe en France: saison 2007-2008. Bull Epidémiol Hebdo 2008; 34: 301-304.
10. Bartosch B, Dubuisson J, Cosset FL. Infectious hepatitis c virus pseudo-particles containing functional e1-e2 envelope protein complexes. J Exp Med 2003; 197: 633-642.
11. Wood JM, Gaines-Das RE, Taylor J, Chakraverty P. Comparison of influenza serological techniques by international collaborative study. Vaccine 1994; 12: 167-174.
12. Snijders TAB. Power and sample size in multilevel linear models. In: Everitt BS, Howell DC, eds. Encyclopedia of Statistics in Behavioral Science, volume 3. Chichester: Wiley, 2005; 1570-1573.
13. McCulloch CE, Searle SR. Generalized, linear, and mixed models. New York: Wiley, 2004; doi: 10.1002/0471722073.
14. Cox DR. Regression models and life-tables. J R Stat Soc Series B Stat Methodol 1972; 34: 187-220.
15. Siev D. Reply to "Nauta jjp, eliminating bias in the estimation of the geometric mean of hi titers" [biologicals 2006;34(3):183-6]. Biologicals 2007; 35: 149-151. author reply 153.
16. Nauta JJ, de Bruijn IA. On the bias in hi titers and how to reduce it. Vaccine 2006; 24: 6645-6646.
17. Davenport FM, Hennessy AV, Francis T Jr. Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. J Exp Med 1953; 98: 641-656.
18. Francis T Jr. On the doctrine of original antigenic sin. Proc Am Philos Soc 1960; 104: 572-578.
19. Steel J, Staeheli P, Mubareka S, Garcia-Sastre A, Palese P, Lowen AC. Transmission of pandemic h1n1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment. J Virol 2010; 84: 21-26.
20. Tu W, Mao H, Zheng J et al. Cytotoxic t lymphocytes established by seasonal human influenza cross-react against 2009 pandemic h1n1 influenza virus. J Virol 2010; 84: 6527-6535.
21. Skowronski DM, De Serres G, Crowcroft NS et al. Association between the 2008-09 seasonal influenza vaccine and pandemic h1n1 illness during spring-summer 2009: four observational studies from Canada. PLoS Med 2010; 7: e1000258.
22. Garten RJ, Davis CT, Russell CA et al. Antigenic and genetic characteristics of swine-origin 2009 a(h1n1) influenza viruses circulating in humans. Science 2009; 325: 197-201.